Share this article Share this article EASTBOURNE, England, April 28, 2021 /PRNewswire/ -- WholisticResearch, the fact-finding blog on rare nootropics and peptides, announced today that it had acquired the domain name previously owned by Adherex Technologies Inc. biopharmaceutical company, committed to discover and develop therapeutics for cancer and cognitive improvement. The CEO of WholisticResearch shared, "I believe that the domain of Adherex is a significant addition to our venture. This move can contribute to providing vendors and consumers with high-quality researched compounds synthesized in our UK labs." This domain acquisition is a notable milestone for both companies as they share the same passion for providing a safer way to deal with cognitive issues and disorders. Together, WholisticResearch, combined with Adherex's promising scientific discoveries, more innovative and potent medical treatment is within our reach.